Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Is Moderna Stock A Buy As It Faces Off With Pfizer, GSK In The Massive RSV Market?
11:21am, Wednesday, 15'th Feb 2023
Is Moderna stock a buy after unveiling promising results for its Pfizer- and GSK-rivaling RSV vaccine? Is MRNA stock a buy now?
Candy? Flowers? These Top Stocks Offer You Something Even Sweeter
05:30am, Tuesday, 14'th Feb 2023
These stocks may reward you over time.
Signal Says Buy the Dip on This Vaccine Stock
11:40am, Monday, 13'th Feb 2023
Moderna Inc (NASDAQ:MRNA) stock was last seen trading at $169.88.
Here are five companies to pick if Goldman Sachs is right about the stock market being flat in 2023
07:02am, Monday, 13'th Feb 2023
Hearts, flowers and CPI data. Get ready for Tuesday.
Betting On Biotech
10:02am, Friday, 10'th Feb 2023
Active investors can navigate the boom or bust biotech sector with the help of strategies like C-suite buying, cash to value and cash flow. Passive investors seeking a defensive position might just pu
Moderna, Inc. (MRNA) is Attracting Investor Attention: Here is What You Should Know
10:34am, Thursday, 09'th Feb 2023
Zacks.com users have recently been watching Moderna (MRNA) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Pandemic Profits In Healthcare
04:26am, Thursday, 09'th Feb 2023
Pfizer and Moderna profited by developing vaccines at a breakneck pace, but should investors add them to their portfolios in 2023? As the race to develop COVID-19 vaccines became paramount, Moderna's
Is Biotech Immunocore About To Make A 25% Price Move?
07:00am, Tuesday, 07'th Feb 2023
The industry is home to some large-cap heavyweights, including Amgen Inc. (NASDAQ: AMGN), Gilead Sciences Inc. (NASDAQ: GILD), Regeneron Pharmaceuticals Inc. (NASDAQ: REGN), Vertex Pharmaceuticals Inc
3 No-Brainer Growth Stocks to Buy in 2023
02:00pm, Friday, 03'rd Feb 2023
These stocks all fell by double digits last year.
Is Moderna Stock a Buy Now?
08:05am, Friday, 03'rd Feb 2023
The company is starting the year on a strong note.
The 7 Most Undervalued Biotech Stocks to Buy in February 2023
02:19pm, Thursday, 02'nd Feb 2023
You don't have to be particularly astute to recognize the importance of the most undervalued biotech stocks to buy. Fundamentally, the enterprises that undergird these names operate on the cutting edg
Moderna to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 23, 2023
07:00am, Thursday, 02'nd Feb 2023
CAMBRIDGE, MA / ACCESSWIRE / February 2, 2023 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it will host a live
Moderna's stock is down as Pfizer lowers revenue estimates for its COVID vaccine for 2023
01:52pm, Tuesday, 31'st Jan 2023
Moderna Inc.'s MRNA shares were down 2.8% in trading on Tuesday. Pfizer Inc. PFE, which makes a competing COVID-19 vaccine to Moderna's Spikevax, on Tuesday put out guidance for 2023, saying it expect
Moderna (MRNA) RSV Jab For Older Adults Gets FDA Breakthrough Tag
09:30am, Tuesday, 31'st Jan 2023
Moderna (MRNA) announces that the FDA granted Breakthrough Therapy Designation to its respiratory syncytial virus (RSV) vaccine candidate, mRNA-1345 for the prevention of respiratory disease in older
The RSV Vaccine Battle Wages On With Moderna Scoring A Win Vs. Pfizer, GSK
09:56am, Monday, 30'th Jan 2023
The Food and Drug Administration granted Moderna's experimental RSV vaccine an expedited review, but Moderna stock dipped Monday.
